网站主页>>>项目整合精选>>>项目整合精选>>>新产品编号:1000333

新产品编号:1000333

Chemical Name: 5-[4-(3,4,5-Trimethoxybenzyloxy)phenyl]-2,3-dihydroimidazo[2,1-a]isoquinoline
项目整合开发状态: Biological Testing
项目研究机构: Novartis (Originator)
合成路线:The reaction of 2-(2-methylphenyl)-4,5-dihydro-1H-imidazole (I) with n-BuLi in tetramethylethylenediamine gives the dilithium salt (II),which is cyclized with 4-(3,4,5-trimethoxybenzyloxy)benzoic acid methyl ester (III),yielding imidazoquinoline (IV).Finally,this compound is dehydrated in refluxing acetic acid or in refluxing toluene catalyzed by p-toluenesulfonic acid.

合成路线:The reaction of 2-(2-methylphenyl)-4,5-dihydro-1H-imidazole (I) with n-BuLi in tetramethylethylenediamine gives the dilithium salt (II),which is cyclized with 4-[2-(3,4,5-trimethoxyphenyl)ethyl]benzoic acid methyl ester (III),yielding imidazoquinoline (IV).Finally,this compound is dehydrated in refluxing acetic acid or in refluxing toluene catalyzed by p-toluenesulfonic acid.
📌 参考资料/链接:
参考文献标题:5-ARYL-2,3-DIHYDROIMIDAZO[2,1-a]ISOQUINOLINES: PLATELET-ACTIVATING FACTOR (PAF) RECEPTOR ANTAGONISTS
文献作者:Houlihan,W.J.
参考来源:Drugs Fut 1990,15(4),355